A randomized controlled trial using patient navigation to increase colonoscopy screening among low-income minorities

Journal of the National Medical Association

Volumn 100, Issue 3, 2008, Pages 278-284

  Christie, Jennifer ^a,b   Itzkowitz, Steven ^a   Lihau Nkanza, Irene ^a   Castillo, Anabella ^a   Redd, William ^a   Jandorf, Lina ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Colonoscopy; Colorectal; Minority health; Screening

Indexed keywords

ADULT; ARTICLE; CANCER RISK; CANCER SCREENING; CLINICAL TRIAL; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT MONITORING; PATIENT REFERRAL; PATIENT SATISFACTION; PILOT STUDY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SAMPLE SIZE; SCREENING TEST;

EID: 41149157013     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-9684(15)31240-2     Document Type: Article

References (29)

1. American Cancer Society Facts and Figures 2007. Atlanta, GA. www.cancer.org. Accessed 07/25/07.
2. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med. 1993;329:1977-1983.
3. Ries LAG, Kosary CL, Hankey BF, et al. SEER Cancer Statistics Review. Bethesda, MD: National Cancer Institute; 1999.
4. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Eng J Med. 1993;328(19):1365-1371.
5. Mandel JS, Church TR, Ederer F, et al. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst. 1999;91(5):434-437.
6. Selby JV, Friedman GD, Quesenberry CP, et al. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992;326(10):653-657.
7. Newcomb PA, Norfleet RG, Storer E, et al. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst. 1992;84:1572-1575.
8. Winawer SJ, Zauber AG, Diaz B, et al. The national polyp study: temporal sequence of evolving colorectal cancer from the normal colon: Prevention of colorectal cancer by colonoscopic polypectomy. Gastrointest Endosc. 1993;329:1977-1981.
9. Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology. 2003;124(2):544-560.
10. Lieberman DA, Weiss DG, Bond JH, et al. Use of colonscopy to screen asymptomatic adults for colorectal cancer. N Engl J Med. 2000;343:162-168.
11. American College of Gastroenteroloy. ACG recommendations on colorectal cancer screening for average risk and higher risk patients in clinical practice. Arlington, VA; 2000.
12. Ozick LA, Jacob L, Donelson SS, et al. Distribution of adenomatous polyps in African-Americans. Am J Gastroenterol. 1995;90(5):758-760.
13. Center for Disease Control and Prevention. Behavioral Risk Factor Surveillance System (BRFSS). 2004. www.cdc.gov. Accessed 07/25/07.
14. New York City Department of Health and Mental Hygiene. 2004. www.nyc.gov/html/doh. Accessed 07/25/07.
15. Karpati A, Lu X, Mostashari F, et al. The Health of East Harlem. NYC Community Health Profiles. 2003;1(5):1-12.
16. McPhee SJ, Richard RJ, Solkowitz SN. Performance of cancer screening in a university general internal medicine practice: comparison with the 1980. American Cancer Society Guidelines. J Gen Intern Med. 1986;1(5):275-281.
17. Zapka JG, Puleo E, Vickers-Lahti M, et al. Healthcare system factors and colorectal cancer screening. Am J Prev Med. 2002;23(1):28-35.
18. Brenes GA, Paskett ED. Predictors of stage of adoption for colorectal cancer screening. Prev Med. 2000;31(4):410-416.
19. Ransohoff DF, Sandler RS. Screening for colorectal cancer. N Engl J Med. 2002;346:40-44.
20. Christie J, Nassisi D, Wilets I, et al. Endoscopic colorectal screening adherence in an emergency department population. J Natl Med Assoc. 2006;98(7):1095-1101.
21. Dietrich AJ, O'Connor GT, Keller A, et al. Cancer: improving early detection and prevention. A community practice randomised trial. BMJ. 1992;304(6828):687-691.
22. Stone EG, Morton SC, Hulscher ME, et al. Interventions that increase use of adult immunization and cancer screening services: a meta-analysis. Ann Intern Med. 2002;136:641-651.
23. Freeman HP, Muth BJ, Kerner JF. Expanding access to cancer screening and clinical follow-up among the medically underserved. Cancer Pract. 1995;3(1):19-30.
24. Tingen MS, Weinrich SP, Heydt DD, et al. Perceived benefits: a predictor of participation in prostate cancer screening. Cancer Nurs. 1998;21(5):349-357.
25. Dohan D, Schrag D. Using navigators to improve care of underserved patients: current practices and approaches. Cancer. 2005;104(4):848-855.
26. Jandorf L, Gutierrez Y, Lopez H, et al. Increasing colorectal cancer screening in an urban neighborhood health clinic. J Urban Health. 2005;82(2):216-224.
27. Psooy BJ, Schreuer D, Borgaonkar J, et al. Patient navigation: improving timeliness in the diagnosis of breast abnormalities. Can Assoc Radiol J. 2004;55(3):145-150.
28. Nash D, Azeez S, Vlahov D, et al. Evaluation of an intervention to increase screening colonoscopy in an urban public hospital setting. J Urban Health. 2006;83(2):231-243.
29. Steinberg ML, Fremont A, Khan DC, et al. Lay patient navigator program implementation for equal access to cancer care and clinical trials: essential steps and initial challenges. Cancer. 2006;107(11):2669-2677.